The invention provides novel compounds having the general formula (I) wherein R1, R2, R3, R4, R5, R6 and n are as described herein, compositions including the compounds and methods of using the compounds. The present compounds are useful as fatty-acid binding protein (FABP) 4 and/or 5 inhibitors and may be used for the treatment or prophylaxis of lipodystrophy, type 2 diabetes, dyslipidemia, atherosclerosis, liver diseases involving inflammation, steatosis and/or fibrosis, such as non-alcoholic fatty liver disease, in particular non-alcoholic steatohepatitis, metabolic syndrome, obesity, chronic inflammatory and autoimmune inflammatory diseases.본 발명은 하기 화학식 I의 신규한 화합물, 상기 화합물을 포함하는 조성물 및 상기 화합물의 사용 방법을 제공한다:[화학식 I]상기 식에서,R1, R2, R3, R4, R5, R6 및 n은 본원에 기재된 바와 같다.
